Pharos Capital Group’s Acquisition of Majority Stake in RhythMedix

Ballard Spahr assisted RhythMedix on the sale. Pharos Capital Group has acquired a majority stake in New Jersey-based RythMedix, a manufacturer and provider of remote cardiac…

This content is for Standard 1 Year members only.
Login Join Now
Sonia Carcano

Author: Sonia Carcano

This content is for Standard 1 Year members only.
Login Join Now